MYLAN 5150 MYLAN 5150 (Nizatidine 150 mg)
Pill imprint MYLAN 5150 MYLAN 5150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer prophylaxis; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 5150 MYLAN 5150
- Strength:
- 150 mg
- Color:
- Purple
- Size:
- 15.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-5150
- Inactive Ingredients:
- ammonia
lactose anhydrous
silicon dioxide
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
isopropyl alcohol
magnesium stearate
butyl alcohol
corn starch
propylene glycol
shellac
dimethicone
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
More about nizatidine
Consumer resources
- Other brands: Axid, Axid Pulvules, Axid AR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
